KEQU (STOCKS)
Kewaunee Scientific Corp
$36.550000
+0.320000 (+0.88%)
Prev close: $36.230000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Thomas D. Hull
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $104.84M
- Employees
- 1,239
- P/E (TTM)
- 11.24
- P/B (TTM)
- 1.39
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2026 (Q4)
|
$1.14 | $0.00 | +0.0000 | +0.00% |
|
Sep 2026 (Q3)
|
$0.28 | $0.00 | +0.0000 | +0.00% |
|
Jun 2026 (Q2)
|
$0.91 | $0.00 | +0.0000 | +0.00% |
|
Mar 2026 (Q1)
|
$1.10 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $282.00M |
| Benefits Costs and Expenses | $268.27M |
| Cost Of Revenue | $201.56M |
| Costs And Expenses | $268.27M |
| Gross Profit | $80.44M |
| Operating Expenses | $63.73M |
| Research and Development | $898.00K |
| Other Operating Expenses | $62.83M |
| Operating Income/Loss | $16.72M |
| Income/Loss From Continuing Operations After Tax | $10.47M |
| Income/Loss From Continuing Operations Before Tax | $13.73M |
| Income Tax Expense/Benefit | $3.27M |
| Income Tax Expense/Benefit, Current | $3.29M |
| Income Tax Expense/Benefit, Deferred | -$20.00K |
| Net Income/Loss | $10.47M |
| Net Income/Loss Attributable To Noncontrolling Interest | $847.00K |
| Net Income/Loss Attributable To Parent | $9.62M |
| Net Income/Loss Available To Common Stockholders, Basic | $9.62M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $3.36 |
| Diluted Earnings Per Share | $3.22 |
| Basic Average Shares | 2,863,000 |
| Diluted Average Shares | 2,983,000 |
| Assets | $178.31M |
| Current Assets | $105.40M |
| Inventory | $30.53M |
| Other Current Assets | $74.86M |
| Noncurrent Assets | $72.91M |
| Fixed Assets | $22.37M |
| Intangible Assets | $16.29M |
| Other Non-current Assets | $34.25M |
| Liabilities | $101.50M |
| Current Liabilities | $48.35M |
| Accounts Payable | $22.46M |
| Wages | $8.82M |
| Other Current Liabilities | $17.07M |
| Noncurrent Liabilities | $53.15M |
| Long-term Debt | $20.08M |
| Other Non-current Liabilities | $33.07M |
| Equity | $76.81M |
| Equity Attributable To Noncontrolling Interest | $2.09M |
| Equity Attributable To Parent | $74.72M |
| Liabilities And Equity | $178.31M |
| Net Cash Flow From Operating Activities | $18.63M |
| Net Cash Flow From Operating Activities, Continuing | $18.63M |
| Net Cash Flow From Investing Activities | -$3.94M |
| Net Cash Flow From Investing Activities, Continuing | -$3.94M |
| Net Cash Flow From Financing Activities | -$19.33M |
| Net Cash Flow From Financing Activities, Continuing | -$19.33M |
| Exchange Gains/Losses | -$917.00K |
| Net Cash Flow | -$5.55M |
| Net Cash Flow, Continuing | -$4.63M |
| Comprehensive Income/Loss | $9.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $847.00K |
| Comprehensive Income/Loss Attributable To Parent | $8.81M |
| Other Comprehensive Income/Loss | -$811.00K |